Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2023-12-26 | BridgeBio Pharma, Inc. | MCCORMICK FRANK
(Director) |
S | Common Stock | D | 100000 | $42.06 - $42.06 | $4,206,000 |
| 2023-12-18 | BridgeBio Pharma, Inc. | Scott Randal W.
(Director) |
S | Common Stock | D | 2000 | $40.00 - $40.00 | $80,000 |
| 2023-12-15 | BridgeBio Pharma, Inc. | Valantine Hannah
(Director) |
S | Common Stock | D | 2915 | $36.12 - $36.12 | $105,289 |
| 2023-12-15 | BridgeBio Pharma, Inc. | Valantine Hannah
(Director) |
M | Common Stock | A | 2915 | $8.45 - $8.45 | $24,631 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |